Effects of dietary factors on drug transport and metabolism: The impact on dosage guidelines in transplant patients

Clinical Pharmacology and Therapeutics

Volumn 85, Issue 4, 2009, Pages 439-443

  Nowack, R ^a   Andrassy, J ^b   Fischereder, M ^b   Unger, M ^c  

^a Centre for Nephrology/Dialysis   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AZATHIOPRINE; BERBERINE; BERGAMOTTIN; BOSWELLIC ACID; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOCHROME P450 3A4; DIGOXIN; DILTIAZEM; GINSENG EXTRACT; GLUCOCORTICOID; GLYCOPROTEIN P; GOMISIN; HERBACEOUS AGENT; HYPERFORIN; IMMUNOSUPPRESSIVE AGENT; INDINAVIR; KAVA; METHYLPREDNISOLONE; MIDAZOLAM; MYCOPHENOLIC ACID; NATURAL PRODUCT; NIFEDIPINE; PLANT EXTRACT; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; UNINDEXED DRUG; VALERIAN;

ALTERNATIVE MEDICINE; ANGELICA SINENSIS; BOSWELLIA; CITRUS FRUIT; CRANBERRY JUICE; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG TRANSPORT; ECHINACEA; ENZYME ACTIVITY; EVENING PRIMROSE; FLUID INTAKE; FOOD DRUG INTERACTION; GARLIC; GINKGO BILOBA; GINSENG; GLYCYRRHIZA; GRAFT REJECTION; GRAPEFRUIT JUICE; HERB DRUG INTERACTION; HUMAN; HYDRASTIS; HYPERICUM PERFORATUM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; PATIENT COUNSELING; PEPPER; PHYTOCHEMISTRY; POMEGRANATE JUICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RED WINE; REVIEW; SABAL; SCHISANDRACEAE; SILYBUM MARIANUM; SOYBEAN; TANACETUM PARTHENIUM; TEA; UNCARIA TOMENTOSA;

BIOLOGICAL TRANSPORT, ACTIVE; FOOD-DRUG INTERACTIONS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES AS TOPIC; TRANSPLANTATION;

EID: 62649137545     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.303     Document Type: Review

References (40)

1. Stoves, J. & Newstead, C.G. Variability of cyclosporine exposure and its relevance to chronic allograft nephropathy: a case-control study. Transplantation 74, 1794-1797 (2002).
2. Utecht, K.N., Hiles, J.J. & Kolesar, J. Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors. Am. J. Health Syst. Pharm. 63, 2340-2348 (2006).
3. Edwards, D.J. 6′, 7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin. Pharmacol. Ther. 65, 237-244 (1999).
4. Breidenbach, T., Kliem, V., Burg, M., Radermacher, J., Hoffmann, M.W. & Klempnauer, J. Profound drop of cyclosporin A whole blood trough levels caused by St. John's Wort (Hypericum perforatum). Transplantation 69, 2229-2230 (2000).
5. Izzo, A.A. & Ernst, E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61, 2163-2175 (2001).
6. Nowack, R., Ballé, C., Birnkammer, F., Koch, W., Sessler, R. & Birck, R. Complementary and alternative medication consumed by renal patients in southern Germany. J. Renal Nutr. (in press).
7. Zhou, S.F., Xue, C.C., Yu, X.Q. & Wang, G. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr. Drug Metab. 8, 526-553 (2007).
8. Zhang, Y. & Benet, L.Z. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet. 40, 159-168 (2001).
9. Bernard, O., Tojcic, J., Journault, K., Perusse, L. & Guillemette, C. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid. Drug Metab. Dispos. 34, 1539-1545 (2006).
10. Moore, L.B. et al. St. John's Wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA 97, 7500-7502 (2000).
11. Hebert, M.F., Park, J.M., Chen, Y.L., Akhtar, S. & Larson, A.M. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J. Clin. Pharmacol. 44, 89-94 (2004).
12. Mai, I. et al. Hyperforin content determines the magnitude of the St. John's Wort-cyclosporine drug interaction. Clin. Pharmacol. Ther. 76, 330-340 (2004).
13. Fukatsu, S. et al. Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient. Drug Metab. Pharmacokinet. 21, 122-125 (2006).
14. Nowack, R. Review article: cytochrome P 450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St. John's wort - and beyond! Nephrology (Carlton). 13, 337-347 (2008).
15. Frank, A. & Unger, M. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. J. Chromatogr. A 1112, 255-262 (2006).
16. Chatterjee, P. & Franklin, M.R. Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab. Dispos. 31, 1391-1397 (2003).
17. Unger, M., Holzgrabe, U., Jacobsen, W., Cummins, C. & Benet, L.Z. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (kava-kava). Planta Med. 68, 1055-1058 (2002).
18. Iwata, H., Tezuka, Y., Kadota, S., Hiratsuka, A. & Watabe, T. Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract. Drug Metab. Dispos. 32, 1351-1358 (2004).
19. Weber, C.C., Reising, K., Müller, W.E., Schubert-Zsilavecz, M. & Abdel-Tawab, M. Modulation of Pgp function by boswellic acids. Planta Med. 72, 507-513 (2006).
20. Weiss, J., Sauer, A., Frank, A. & Unger, M. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab. Dispos. 33, 1580-1583 (2005).
21. Yoo, H.H., Lee, M., Lee, M.W., Lim, S.Y., Shin, J. & Kim, D.H. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2. Planta Med. 73, 444-450 (2007).
22. Gurley, B.J. et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin. Pharmacol. Ther. 77, 415-426 (2005).
23. Gurley, B.J. et al. Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Clin. Pharmacol. Ther. 83, 61-69 (2008).
24. Xin, H.W. et al. Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers. Br. J. Clin. Pharmacol. 64, 469-475 (2007).
25. Sandhu, R.S., Prescilla, R.P., Simonelli, T.M. & Edwards, D.J. Influence of goldenseal root on the pharmacokinetics of indinavir. J. Clin. Pharmacol. 43, 1283-1288 (2003).
26. Gurley, B.J. et al. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab. Dispos. 35, 240-245 (2007).
27. Wu, X., Li, Q., Xin, H., Yu, A. & Zhong, M. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur. J. Clin. Pharmacol. 61, 567-572 (2005).
28. Pan, G.Y., Wang, G.J., Liu, X.D., Fawcett, J.P. & Xie, Y.Y. The involvement of P-glycoprotein in berberine absorption. Pharmacol. Toxicol. 91, 193-197 (2002).
29. Jürgen Roth, H. & Wintergalen, M. Unusual high levels of ciclosporin in a female patient - the impact of lifestyle? Clin. Lab. 51, 426-427 (2005).
30. Uesawa, Y. & Mohri, K. Effects of cranberry juice on nifedipine pharmacokinetics in rats. J. Pharm. Pharmacol. 58, 1067-1072 (2006).
31. Grenier, J., Fradette, C., Morelli, G., Merritt, G.J., Vranderick, M. & Ducharme, M.P. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin. Pharmacol. Ther. 79, 255-262 (2006).
32. Chan, W.K., Nguyen, L.T., Miller, V.P. & Harris, R.Z. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine. Life Sci. 62, PL135-PL142 (1998).
33. Piver, B., Berthou, F., Dreano, Y. & Lucas, D. Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non-volatile red wine components. Toxicol. Lett. 125, 83-91 (2001).
34. Tsunoda, S.M. et al. Red wine decreases cyclosporine bioavailability. Clin. Pharmacol. Ther. 70, 462-467 (2001).
35. Budzinski, J.W., Foster, B.C., Vandenhoek, S. & Arnason, J.T. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7, 273-282 (2000).
36. Malhotra, S., Bailey, D.G., Paine, M.F. & Watkins, P.B. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furanocoumarins. Clin. Pharmacol. Ther. 69, 14-23 (2001).
37. Nowack, R. & Nowak, B. Herbal teas interfere with cyclosporin levels in renal transplant patients. Nephrol. Dial. Transplant. 20, 2554-2556 (2005).
38. Bolley, R., Zülke, C., Kammerl, M., Fischereder, M. & Krämer, B.K. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. Transplantation 73, 1009 (2002).
39. Dalvi, S.S., Nyak, V.K., Pohujani, S.M., Desai, N.K., Kshirsagar, N.A. & Gupta, K.C. Effect of guggulipid on bioavailability of diltiazem and propranolol. J. Assoc. Physicians India 42, 454-455 (1994).
40. Gurley, B.J. et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 22, 525-539 (2005).